Laurel Oak Wealth Management, Llc
Source: SEC Form 13F · as of Mar 2026Laurel Oak Wealth Management, Llc holds 20 biotech & pharma companies tracked by BioSniper, totaling $17.7M in value as of Mar 2026 (SEC Form 13F).
Companies held
20
Total value held
$17.7M
| Company | Shares | Value |
|---|---|---|
| JNJJOHNSON & JOHNSON | 18,409 | $4.5M |
| LLYELI LILLY & Co | 3,896 | $3.6M |
| MRKMerck & Co., Inc. | 11,876 | $1.4M |
| TEVATeva Pharmaceutical Industries Limited | 36,352 | $1.1M |
| AMGNAMGEN INC | 2,618 | $921K |
| ABBVAbbVie Inc. | 3,665 | $797K |
| BMYBRISTOL MYERS SQUIBB CO | 12,052 | $731K |
| PFEPFIZER INC | 22,276 | $626K |
| PMPhilip Morris International Inc | 3,646 | $603K |
| MCKMcKesson Corporation | 603 | $522K |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 1,395 | $377K |
| APLSApellis Pharmaceuticals, Inc. | 8,465 | $341K |
| SNYSanofi | 6,982 | $336K |
| ABTABBOTT LABORATORIES | 3,126 | $321K |
| NVONovo Nordisk A/S | 8,239 | $303K |
| CAHCardinal Health Inc. | 1,420 | $300K |
| GILDGILEAD SCIENCES, INC. | 2,033 | $283K |
| ELVElevance Health Inc. | 896 | $262K |
| GMOptec International, Inc. | 3,253 | $242K |
| NVAXNOVAVAX INC | 15,540 | $126K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.